BLACK BEAR OFFSHORE MASTER FUND LP

CIK 1275688 · last filed 2009-09-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$271.24M

Companies

4

Total Filings

74

Lifetime Open-Market Net

-$3.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted 10%+ Owner 1,007,637 $4.25M 27 2009-09-30
MTG 10%+ Owner 9,366,039 $28.96 $271.24M $321.1K 2 2009-07-10
CASSAVA SCIENCES INC (PTIE) Delisted 10%+ Owner 4,186,238 $4.02M 34 2009-07-09
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted 10%+ Owner 12,812,168 -$12.27M 11 2008-08-29

Recent Filings · Page 2 of 8

74 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2009-02-12 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Buy (P) +138,223 $62.0K EDGAR
2009-02-03 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Buy (P) +31,739 $14.4K EDGAR
2009-01-29 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Buy (P) +47,458 $22.0K EDGAR
2009-01-22 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Buy (P) +247,207 $120.3K EDGAR
2009-01-15 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Buy (P) +91,482 $40.1K EDGAR
2009-01-05 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Buy (P) +423,024 $157.0K EDGAR
2008-12-31 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Buy (P) +448,676 $155.4K EDGAR
2008-08-29 AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Sell (S) −4,192,713 -$89.15M EDGAR
2008-06-25 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Sell (S) −2,373,554 -$2.99M EDGAR
2008-06-06 AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Buy (P) +111,207 $3.33M EDGAR
Showing 1120 of 74
Page 2 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.